Showing results (51-60 of 372) with videos related to
Sort By:
Pageof 38
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Can ISSWM be used for making treatment decisions?Pierre Morel, Giampaolo MerliniClinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Diagnostic challenges of amyloidosis in Waldenström macroglobulinemiaGiovanni Palladini, Giampaolo MerliniBest Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal IgM-related AL amyloidosisPaolo Milani, Giampaolo MerliniNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2016
Systemic amyloidosis: novel therapies and role of biomarkersMario Nuvolone, Giampaolo MerliniKidney International|February 22, 2024
Mining the amyloid-plaque proteome to uncover disease mechanisms in renal amyloidosesMario Nuvolone, Giampaolo MerliniClinical Chemistry and Laboratory Medicine|March 5, 2016
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosisGiovanni Palladini, Paolo Milani, Andrea Foli, et al.Blood|January 26, 2006
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in ALGiovanni Palladini, Francesca Lavatelli, Paola Russo, et al.JPEN. Journal of Parenteral and Enteral Nutrition|September 28, 2013
Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatmentRiccardo Caccialanza, Giovanni Palladini, Catherine Klersy, et al.Clinical Lymphoma & Myeloma|April 14, 2009
AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entityGiovanni Palladini, Paola Russo, Tiziana Bosoni, et al.Blood|February 1, 2015
A practical approach to the diagnosis of systemic amyloidosesCarlos Fernández de Larrea, Laura Verga, Patrizia Morbini, et al.Pageof 38